Ming‐Hsin Yeh
Chung Shan Medical University Hospital(TW)Chung Shan Medical University(TW)
Publications by Year
Research Areas
Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research, Breast Lesions and Carcinomas, Cytokine Signaling Pathways and Interactions, MicroRNA in disease regulation
Most-Cited Works
- → Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancer(2016)97 cited
- → Lapatinib–induced NF-kappaB activation sensitizes triple-negative breast cancer cells to proteasome inhibitors(2013)73 cited
- → Hepatoma‐derived growth factor regulates breast cancer cell invasion by modulating epithelial–mesenchymal transition(2012)71 cited
- → MEK inhibitors induce Akt activation and drug resistance by suppressing negative feedback ERK‐mediated HER2 phosphorylation at Thr701(2017)60 cited
- → Lapatinib increases motility of triple-negative breast cancer cells by decreasing miRNA-7 and inducing Raf-1/MAPK-dependent interleukin-6(2015)39 cited
- → Lapatinib-Mediated Cyclooxygenase-2 Expression via Epidermal Growth Factor Receptor/HuR Interaction Enhances the Aggressiveness of Triple-Negative Breast Cancer Cells(2013)36 cited
- → Multi-center study on patient selection for and the oncologic safety of intraoperative radiotherapy (IORT) with the Xoft Axxent® eBx® System for the management of early stage breast cancer in Taiwan(2017)21 cited
- → Trichostatin A Suppresses EGFR Expression through Induction of MicroRNA-7 in an HDAC-Independent Manner in Lapatinib-Treated Cells(2014)20 cited
- → Clinical and pathologic risk factors of tumor recurrence in patients with node-negative early breast cancer after mastectomy(2013)16 cited
- → Chaperone‐mediated autophagy degrade Dicer to promote breast cancer metastasis(2023)12 cited